Serum cholinesterase combined with platelet-to-hemoglobin ratio for predicting survival prognosis in stage I-III colorectal cancer patients undergoing radical surgery: a retrospective cohort study

Serum cholinesterase combined with platelet-to-hemoglobin ratio for predicting survival prognosis in stage I-III colorectal cancer patients undergoing radical surgery: a retrospective cohort study

Abstract Background Although surgery-based comprehensive therapy is highly effective for treating stage I–III colorectal cancer, heterogeneity in survival trajectories still exists, necessitating precise prognostic stratification. Serum cholinesterase (CHE) and the platelet-to-hemoglobin ratio (PHR)...

Full description

Saved in:
Bibliographic Details
Main Authors: Luyu Huang, Kai Zhao, Hongnan Lu, Wei He, Dazhuang Miao, Yan Wang, Bingcai Li, Qi Wang, Shixiong Jiang, Yunhe Jia
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Gastroenterology
Subjects:
Colorectal cancer
Cholinesterase
Platelet-to-hemoglobin ratio
Prognosis
Biomarker
CHE-PHR
Online Access:https://doi.org/10.1186/s12876-025-03932-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12876-025-03932-w

Similar Items